Tags

Type your tag names separated by a space and hit enter

Galantamine for Alzheimer's disease and mild cognitive impairment.
Neuroepidemiology. 2007; 28(2):116-7.N

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

News

Language

eng

PubMed ID

17409773

Citation

Cusi, Cristina, et al. "Galantamine for Alzheimer's Disease and Mild Cognitive Impairment." Neuroepidemiology, vol. 28, no. 2, 2007, pp. 116-7.
Cusi C, Cantisani TA, Celani MG, et al. Galantamine for Alzheimer's disease and mild cognitive impairment. Neuroepidemiology. 2007;28(2):116-7.
Cusi, C., Cantisani, T. A., Celani, M. G., Incorvaia, B., Righetti, E., & Candelise, L. (2007). Galantamine for Alzheimer's disease and mild cognitive impairment. Neuroepidemiology, 28(2), 116-7.
Cusi C, et al. Galantamine for Alzheimer's Disease and Mild Cognitive Impairment. Neuroepidemiology. 2007;28(2):116-7. PubMed PMID: 17409773.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Galantamine for Alzheimer's disease and mild cognitive impairment. AU - Cusi,Cristina, AU - Cantisani,Teresa Anna, AU - Celani,Maria Grazia, AU - Incorvaia,Barbara, AU - Righetti,Enrico, AU - Candelise,Livia, AU - ,, Y1 - 2007/04/04/ PY - 2007/4/6/pubmed PY - 2007/5/23/medline PY - 2007/4/6/entrez SP - 116 EP - 7 JF - Neuroepidemiology JO - Neuroepidemiology VL - 28 IS - 2 SN - 0251-5350 UR - https://www.unboundmedicine.com/medline/citation/17409773/Galantamine_for_Alzheimer's_disease_and_mild_cognitive_impairment_ L2 - https://www.karger.com?DOI=10.1159/000101510 DB - PRIME DP - Unbound Medicine ER -